Previous Close | 12.85 |
Open | 12.93 |
Bid | 13.26 x N/A |
Ask | 13.55 x N/A |
Day's Range | 12.91 - 13.43 |
52 Week Range | 5.36 - 15.60 |
Volume | |
Avg. Volume | 77 |
Market Cap | N/A |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | Aug 05, 2024 - Aug 09, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
SAN FRANCISCO, May 16, 2024--Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform, today announced the appointment of Anja Manuel to the company’s Board of Directors. Ms. Manuel is a co-founder and principal in Rice, Hadley, Gates & Manuel LLC, a strategic consulting firm founded in 2009 that helps U.S. companies navigate international markets and regulatory issues, and a former U.S. government official.
The United States stock market has shown robust performance recently, with a 1.0% increase over the past week and a significant 27% rise over the last year. In this thriving economic environment, stocks with high insider ownership can be particularly appealing as they often indicate strong confidence from those who know the company best.
Hims & Hers Health, Inc. ( NYSE:HIMS ) just released its first-quarter report and things are looking bullish. It was...